Skip to content
Sleep & circadian healthResearch article4 min read

Genetic study: morning-type people had lower breast cancer risk; longer sleep hinted at higher risk

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study. · BMJ (Clinical research ed.) · 2019 · Original paper ↗

Key takeaway

Using genetic variants as proxies, a Mendelian randomisation study found morning preference was linked to lower breast cancer risk (odds ratio 0.88 per category, 95% CI 0.82 to 0.93) and longer sleep to higher risk (1.19 per hour, 1.02 to 1.39). Insomnia results were inconsistent, and genetic proxies for sleep habits can be imperfect, so this is suggestive rather than proof.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Observational studies link sleep habits with breast cancer, but they cannot show whether sleep itself changes risk. The authors used Mendelian randomisation, which uses inherited genetic variants as a natural experiment, to test whether chronotype, insomnia symptoms and sleep duration affect breast cancer risk in women.

Who and how

Mendelian randomisation study using UK Biobank (156 848 women, 7784 with breast cancer) for multivariable regression and one-sample analysis, plus summary data from the Breast Cancer Association Consortium (BCAC; 122 977 cases and 105 974 controls) for two-sample analysis. Exposures were self-reported chronotype, insomnia symptoms and sleep duration, and genetic variants linked to them: 341 single nucleotide polymorphisms (SNPs) for chronotype, 91 for sleep duration and 57 for insomnia symptoms. The outcome was breast cancer diagnosis, and sensitivity analyses addressed horizontal pleiotropy.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    In regression using UK Biobank, morning preference was associated with less breast cancer (hazard ratio 0.95 per category increase, 95% CI 0.93 to 0.98). There was little evidence for an association with sleep duration or insomnia symptoms.
  2. 2
    One-sample Mendelian randomisation gave an estimate of 0.85 (0.70 to 1.03) per category for morning preference, which includes 1 and so is only supportive, with imprecise estimates for sleep duration and insomnia.
  3. 3
    Two-sample analysis with BCAC data supported a protective effect of morning preference (inverse variance weighted odds ratio 0.88, 95% CI 0.82 to 0.93 per category) and an adverse effect of longer sleep (1.19, 1.02 to 1.39 per hour), for both oestrogen receptor positive and negative cancers.
  4. 4
    Evidence for insomnia symptoms was inconsistent. Results were largely robust to sensitivity analyses for horizontal pleiotropy.

Limits & uncertainty

  1. 1
    The sleep exposures in the regression analyses were self-reported, and the one-sample estimate for morning preference was imprecise, with a confidence interval including 1.
  2. 2
    Mendelian randomisation depends on assumptions about the genetic variants; effects on other pathways (pleiotropy) remain possible even though sensitivity analyses were largely reassuring.
  3. 3
    The effect of sleep duration is described only as suggestive, and results for insomnia were inconsistent, so those findings cannot be relied on.
  4. 4
    This reading is based on the abstract only.

What to take from it

Preference for mornings, which is partly inherited, appeared protective, while longer sleep hinted at higher risk. These are population-level estimates per category or per hour, not predictions for any one woman. They do not tell anyone to change sleep habits or to worry; screening and prevention decisions belong with a clinician.

Reading your own data

Wearables estimate sleep duration and timing, so you can follow your own average sleep length and bedtime over weeks on the same device. Do not read these numbers as a cancer risk score: sleep tracker estimates are not the same as the self-reported measures used here.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Objective

To examine whether sleep traits have a causal effect on risk of breast cancer.

Design

Mendelian randomisation study.

Setting

UK Biobank prospective cohort study and Breast Cancer Association Consortium (BCAC) case-control genome-wide association study.

Participants

156 848 women in the multivariable regression and one sample mendelian randomisation (MR) analysis in UK Biobank (7784 with a breast cancer diagnosis) and 122 977 breast cancer cases and 105 974 controls from BCAC in the two sample MR analysis.

Exposures

Self reported chronotype (morning or evening preference), insomnia symptoms, and sleep duration in multivariable regression, and genetic variants robustly associated with these sleep traits.

Main outcome measure

Breast cancer diagnosis.

Results

In multivariable regression analysis using UK Biobank data on breast cancer incidence, morning preference was inversely associated with breast cancer (hazard ratio 0.95, 95% confidence interval 0.93 to 0.98 per category increase), whereas there was little evidence for an association between sleep duration and insomnia symptoms. Using 341 single nucleotide polymorphisms (SNPs) associated with chronotype, 91 SNPs associated with sleep duration, and 57 SNPs associated with insomnia symptoms, one sample MR analysis in UK Biobank provided some supportive evidence for a protective effect of morning preference on breast cancer risk (0.85, 0.70, 1.03 per category increase) but imprecise estimates for sleep duration and insomnia symptoms. Two sample MR using data from BCAC supported findings for a protective effect of morning preference (inverse variance weighted odds ratio 0.88, 95% confidence interval 0.82 to 0.93 per category increase) and adverse effect of increased sleep duration (1.19, 1.02 to 1.39 per hour increase) on breast cancer risk (both oestrogen receptor positive and oestrogen receptor negative), whereas evidence for insomnia symptoms was inconsistent. Results were largely robust to sensitivity analyses accounting for horizontal pleiotropy.

Conclusions

Findings showed consistent evidence for a protective effect of morning preference and suggestive evidence for an adverse effect of increased sleep duration on breast cancer risk.

Sources & attribution

Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study.

Richmond RC, Anderson EL, Dashti HS, Jones SE, Lane JM, Strand LB, Brumpton B, Rutter MK, Wood AR, Straif K, Relton CL, Munafò M, Frayling TM, Martin RM, Saxena R, Weedon MN, Lawlor DA, Smith GD.

BMJ (Clinical research ed.) · 2019-06-26

DOI: 10.1136/bmj.l2327 ↗PubMed · 31243001 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

In-depth explainersRead study →
·Cohort study

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

In-depth explainersRead study →
·Randomised trial

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

In-depth explainersRead study →
·Cohort study

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

In-depth explainersRead study →
Sleep & circadian health →